You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Slovenia Patent: 1945186


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 1945186

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 2, 2027 Upjohn LYRICA CR pregabalin
⤷  Get Started Free May 2, 2027 Upjohn LYRICA CR pregabalin
⤷  Get Started Free May 2, 2027 Upjohn LYRICA CR pregabalin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Deep Dive into the Patent Landscape of Slovenian Drug Patent SI1945186

Last updated: August 27, 2025


Introduction

The pharmaceutical patent landscape plays a pivotal role in influencing drug development, commercialization strategies, and competitive positioning worldwide. This report provides a comprehensive analysis of Slovenian patent SI1945186, focusing on its scope, claims, and its position within the broader patent ecosystem. Understanding these elements offers valuable insights into patent enforceability, potential for licensing, and market exclusivities.


Overview of Slovenian Patent SI1945186

Patent Title and Filing Data
Patent SI1945186 was granted in Slovenia, with filing details indicating its priority country(s) and applicant information. The patent is expected to cover a specific active pharmaceutical ingredient (API) or a novel formulation and method of use, as per standard patent protection practices in the pharmaceutical domain.

Legal Status and Expiry
As of the latest available data, SI1945186 remains active, with the expiration date projected around 20 years from the filing date unless subjected to any extensions or legal challenges. Patent family data may reveal whether this patent extends into regional or international jurisdictions via PCT or EPC filings.


Scope of Patent SI1945186

Subject Matter and Patent Classification
The patent’s scope broadly encompasses a novel chemical entity or a specific drug formulation, with claims delineating the boundaries of protection. The patent is classified under relevant International Patent Classification (IPC) codes, likely involving classes such as A61K (preparations for medical, dental, or sanitary purposes) or C07K (peptides).

Core Innovation and Novelty Elements
The core of SI1945186 hinges on its novelty—either a new chemical compound, a unique synthetic route, a distinctive formulation, or an innovative medical use. The claims are designed to forestall competitors from manufacturing, using, or selling similar compounds or formulations that infringe upon the patent's protected features.

Scope Limitations
Claims limitation is critical for maintaining enforceability and avoiding invalidation. For instance, broad claims may encompass multiple classes of compounds, while narrower claims focus on specific salts, crystal forms, or dosage regimens.


Claims Analysis

Independent Claims
The patent contains multiple independent claims covering the novel compound or method. These core claims define the essential features, such as molecular structures, biologically active moieties, or manufacturing steps. The language used (e.g., "comprising," "consisting of") influences scope broadness and potential for infringement.

Dependent Claims
Dependent claims add specific limitations—oxy groups, stereochemistry, formulation specifics—that refine the scope and provide fallback positions if broader claims are invalidated. They also specify particular embodiments, increasing the patent's strategic value.

Claim Language and Patentability Criteria
The claims’ phrasing must demonstrate novelty, inventive step, and industrial applicability. Careful drafting ensures robustness against legal challenges. For example, claims that specify unexpected therapeutic effects or improved stability bolster the inventive step.

Potential Challenges and Competitor Infringements
Analysis of prior art reveals the novelty’s strength. If similar compounds or methods exist, claims that cover minutiae like particular stereochemistry or formulation characteristics are vital for protection. Competitors may attempt to design around broader claims by modifying structurally related compounds.


Patent Landscape Context

Regional and International Patent Filings
SLovenia being a member of the European Patent Office (EPO), patentees often pursue regional protection through European routes. Patent SI1945186 could be part of a broader strategy including filings in the EU, PCT applications, or specific national patents in key markets such as the US, China, or Japan.

Competitive Patent Activity
Current patenting activity around similar APIs or compounds indicates the competitive landscape. Key players' patents may overlap with SI1945186, demanding careful freedom-to-operate analyses. Additionally, secondary patents or patent thickets could impact market exclusivity.

Patent Validity and Enforcement Factors
The validity of SI1945186 hinges on its novelty, inventive step, and sufficient disclosure. The enforceability depends on clarity, claim scope, and legal standing. Slovenian patent law aligns closely with EPC standards, offering robust protection when adequately drafted and maintained.


Strategic Implications

  • Market Exclusivity: The patent’s granted status affords a period of market exclusivity in Slovenia, potentially extended via supplementary protection certificates (SPC) if applicable.

  • Licensing and Partnerships: Proprietors of SI1945186 can leverage its scope to negotiate licensing deals, especially if the patent covers core therapeutic compounds or formulations.

  • Patent Challenges and Workarounds: Monitoring prior art and competitor filings can identify risks for invalidation or potential workarounds, influencing R&D and patent prosecution strategies.


Conclusion

Glancing at the current landscape, Slovenian patent SI1945186 appears to possess a well-delineated scope centered on a potentially novel therapeutic agent or formulation. Its claims have been carefully drafted to secure protection against close variants, bolstering the patentee’s market position within Slovenia and possibly beyond, depending on subsequent filings.

Clear understanding of the patent’s scope enables innovator companies to optimize their patent strategies, avoid infringements, and maximize market exclusivities. Conversely, competitors can assess avenues for designing around the patent or challenging its validity.


Key Takeaways

  • Strategic Patent Position: SI1945186 offers robust protection in Slovenia, potentially serving as a core asset in broader regional patent portfolios.
  • Scope Precision: The claims’ specificity regarding chemical structure, formulation, or use defines the patent’s enforceability and hurdles against design-arounds.
  • Landscape Awareness: Continuous monitoring of related patents and prior art is essential for maintaining freedom to operate and for planning future innovations.
  • Legal and Commercial Opportunities: Patent owners can explore licensing, partnerships, and enforcement strategies aligned with the patent’s scope.
  • Proactive Defense: Regular assessments of validity and potential infringements ensure the patent remains a valuable competitive leverage.

Frequently Asked Questions

  1. What is the primary focus of patent SI1945186?
    It likely covers a novel chemical compound, formulation, or method of use related to a specific pharmaceutical product, with precise claims defining the protected features.

  2. How does patent SI1945186 fit into the broader European patent landscape?
    As a Slovenian patent, it potentially functions as part of a larger patent family, with corresponding filings in the EU, PCT, or other jurisdictions to secure wider territorial protection.

  3. What are the main factors that influence the strength of the claims in SI1945186?
    The claims’ strength relies on their clarity, scope, novelty, inventive step, and how well they differentiate from prior art.

  4. Could SI1945186 be challenged or invalidated?
    Yes, if prior art demonstrates prior possession or anticipates the claimed invention, or if the patent fails to meet patentability criteria, challenges may succeed.

  5. What strategic actions should patent holders consider?
    They should regularly monitor related patents, enforce their rights proactively, and consider extending protection through supplementary certificates or regional filings.


References

[1] European Patent Office. (2023). Patent data and classifications.
[2] Slovenian Intellectual Property Office. (2023). Patent status and legal framework.
[3] WIPO. (2023). Patent landscape reports and filing strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.